Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab.
Chandrakasan S, Jordan MB, Baker A, Behrens EM, Bhatla D, Chien M, Eckstein OS, Henry MM, Hermiston ML, Hinson A, Leiding JW, Oladapo A, Patel SA, Pednekar P, Ray A, Dávila Saldaña BJ, Sarangi SN, Walkovich K, Yee JD, Zoref-Lorenz A, Allen CE.
Chandrakasan S, et al. Among authors: sarangi sn.
Blood Adv. 2024 Mar 1:bloodadvances.2023012217. doi: 10.1182/bloodadvances.2023012217. Online ahead of print.
Blood Adv. 2024.
PMID: 38429096